据悉，该债券简称"16中海01"，发行规模为60亿元，当前余额为19亿元，每手派发利息为36.00元(含 税)。 中国海外发展(00688)发布公告，中海企业发展集团有限公司(原中海地产集团有限公司，以下简称"发行 人")公开发行2016年公司债券(第一期)将于2025年8月23日(如遇法定节假日或休息日，则顺延至其后的 第1个交易日，顺延期间付息款项不另计利息)开始支付自2024年8月23日至2025年8月22日期间(以下简 称"本年度")的利息。 ...

中国海外发展(00688)发布公告，该公司全资附属公司中海企业发展集团有限公司2021年面向专业投资 者公开发行公司债券(第三期)(品种二)将于2025年8月9日(如遇法定节假日或休息日，则顺延至其后的第 1个交易日，顺延期间付息款项不另计利息)支付自2024年8月9日至2025年8月8日期间的利息。 据悉，该债券简称"21中海06"，债券余额15亿元，当前票面利率3.25%。 ...

据悉，该债券简称"21中海06"，债券余额15亿元，当前票面利率3.25%。 智通财经APP讯，中国海外发展(00688)发布公告，该公司全资附属公司中海企业发展集团有限公司2021 年面向专业投资者公开发行公司债券(第三期)(品种二)将于2025年8月9日(如遇法定节假日或休息日，则 顺延至其后的第1个交易日，顺延期间付息款项不另计利息)支付自2024年8月9日至2025年8月8日期间的 利息。 ...

本海外監管公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市 規則」）第13.10B條刊發。 中國海外發展有限公司（「本公司」）於二零二一年八月四日及其後刊發了關於中海企 業發展集團有限公司（本公司全資附屬公司）2021年面向專業投資者公開發行公司債券 （第三期）的公告。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：688） 海外監管公告 根據有關規定，中海企業發展集團有限公司已經於 深圳證券交易所網站 （http://www.szse.cn）上載了《中海企業發展集團有限公司2021年面向專業投資者公開 發行公司債券（第三期）（品種二）2025年付息公告》。 為遵守上市規則第13.10B條，該等上載資料亦刊登於聯交所「披露易」中文版網站 （https://www.hkexnews.hk）。 承董事局命 中國海外發展有限公司 主席兼執行董事 顏建國 香港，二零二五年八月七日 於本公告日期，顏建 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：688） 海外監管公告 本海外監管公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市 規則」）第13.10B條刊發。 中國海外發展有限公司（「本公司」）於二零一六年八月十八日及其後刊發了關於中海 企業發展集團有限公司（前稱「中海地產集團有限公司」，本公司全資附屬公司）公開 發行2016年公司債券（第一期）的公告。 根據有關規定，中海企業發展集團有限公司已經於 上海證券交易所 （http://www.sse.com.cn）的網站上載了《中海地產集團有限公司公開發行2016年公司債 券（第一期）2025年付息公告》。 為遵守上市規則第13.10B條，該等上載資料亦刊登於聯交所「披露易」中文版網站 （https://www.hkexnews.hk）。 承董事局命 中國海外發展有限公司 主席兼執行董事 顏建國 香港，二零二五年八月七日 於本公告日期，顏建國 ...

Group 1: Housing Fund Policy Adjustment - Wenzhou has optimized and adjusted multiple housing fund policies to support rigid and improved housing demand, increasing the maximum loan limit for couples from 1 million to 1.3 million yuan and for single contributors from 650,000 to 800,000 yuan, enhancing purchasing power for contributors [1] Group 2: Sales Performance of Real Estate Companies - China Overseas Development reported a contract property sales amount of approximately 11.85 billion yuan in July, a year-on-year decrease of 10.2%, with a sales area of about 660,200 square meters, an increase of 20.8% [2] - Yuexiu Property disclosed a contract sales amount of approximately 6.006 billion yuan in July, a year-on-year increase of about 19.5%, with a contract sales area of approximately 174,200 square meters, a year-on-year decrease of about 18.9% [3] - Poly Real Estate reported a contract sales amount of approximately 2.8 billion yuan in July, with a contract sales area of about 95,000 square meters and an average contract sales price of approximately 29,300 yuan per square meter [4] - Agile Group announced a total pre-sale amount of approximately 520 million yuan in July, corresponding to a construction area of 59,000 square meters, with an average price of approximately 8,810 yuan per square meter [5]

Core Insights - The Shanghai real estate market saw a total of 4,711 new homes sold in June 2025, representing a month-on-month decrease of 0.98% compared to May [1] - In June, the Fengxian district recorded 100 new home registrations, with a total transaction area of 11,370 square meters and a transaction value of approximately 476.77 million yuan [1] Sales Performance - The top-selling properties in June included: - Xiangyu Jiangwan Yufu in Jinhui with 19 registrations, ranking first - China Railway Construction Xiyu in Xidu with 16 registrations, ranking second [5] - The detailed sales data for June includes: - Xiangyu Jiangwan Yufu: 19 units, 1,654 square meters, 59.78 million yuan - China Railway Construction Xiyu: 16 units, 1,648 square meters, 67.48 million yuan - Zhongjian Yujingyuan: 12 units, 1,459 square meters, 78.00 million yuan - Other notable properties include Shangjiangnan Jinghuimingting, Zhongjian Haiyuefu, and others with varying sales figures [6][7]

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Group 1 - The core point of the article indicates that China Overseas Development reported a cumulative contract property sales amount of approximately RMB 132 billion before July 2025, representing a year-on-year decrease of 18.3% [1] - In July, the contract property sales amount was approximately RMB 11.85 billion, showing a year-on-year decline of 10.2% [1]

Core Insights - In July, China Overseas Development reported a contract property sales amount of approximately 11.85 billion yuan, representing a year-on-year decline of 10.2% [1] - The corresponding sales area was approximately 660,200 square meters, showing a year-on-year increase of 20.8% [1] Sales Performance - The total contract property sales amount for July was about 11.85 billion yuan [1] - The year-on-year decrease in sales amount was 10.2% [1] - The sales area increased to approximately 660,200 square meters, marking a 20.8% year-on-year rise [1]